Heska Corp. reports improved revenue, profit for 1Q

LOVELAND — Heska Corp. (Nasdaq: HSKA), a Loveland-based provider of veterinary diagnosic tools and products, on Thursday reported an increase in revenue and profit for its first quarter that ended March 31, compared with the first quarter of 2014.

First-quarter revenue was $22.9 million, up 10 percent compared with $20.8 million for the same period a year ago. Profit was $598,000, or 9 cents per share, for the quarter, compared with $192,000 in the first quarter last year.

As of March 31, Heska had $5.7 million in cash and working capital of $19.2 million.

SPONSORED CONTENT

Empowering communities

Rocky Mountain Health Plans (RMHP), part of the UnitedHealthcare family, has pledged its commitment to uplift these communities through substantial investments in organizations addressing the distinct needs of our communities.

Heska shares have climbed 44 percent since the beginning of the year. The stock has more than doubled in the last 12 months. Shares were trading at $26.77 mid-day Thursday.

Heska’s offerings, mainly for dogs and cats, include blood-testing instruments and supplies, digital imaging products, software and services, and single-use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.